Skip to main content

Moxifloxacin (International)

In the US, Moxifloxacin (moxifloxacin ophthalmic) is a member of the drug class quinolones and fluoroquinolones and is used to treat Anthrax, Anthrax Prophylaxis, Bacterial Infection, Bronchitis, Cutaneous Bacillus anthracis, Intraabdominal Infection, Plague, Plague Prophylaxis, Pneumonia, Prostatitis, Sinusitis, Skin and Structure Infection, Skin or Soft Tissue Infection and Tuberculosis - Active.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01MA14,S01AE07

CAS registry number (Chemical Abstracts Service)

0151096-09-2

Chemical Formula

C21-H24-F-N3-O4

Molecular Weight

401

Therapeutic Category

Antibacterial: Fluoroquinolone (gyrase inhibitor)

Chemical Name

1-cyclopropyl-6-fluoro-1,4-dihydro-8-metoxy-7[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs